URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers

MLA

Zhiwen Ding, et al. “URI Alleviates Tyrosine Kinase Inhibitors-Induced Ferroptosis by Reprogramming Lipid Metabolism in P53 Wild-Type Liver Cancers.” Nature Communications, vol. 14, no. 1, Oct. 2023, pp. 1–20. EBSCOhost, https://doi.org/10.1038/s41467-023-41852-z.

APA

Zhiwen Ding, Yufei Pan, Taiyu Shang, Tianyi Jiang, Yunkai Lin, Chun Yang, Shujie Pang, Xiaowen Cui, Yixiu Wang, Xiao fan Feng, Mengyou Xu, Mengmiao Pei, Yibin Chen, Xin Li, Jin Ding, Yexiong Tan, Hongyang Wang, Liwei Dong, & Lu Wang. (2023). URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nature Communications, 14(1), 1–20. https://doi.org/10.1038/s41467-023-41852-z

Chicago

Zhiwen Ding, Yufei Pan, Taiyu Shang, Tianyi Jiang, Yunkai Lin, Chun Yang, Shujie Pang, et al. 2023. “URI Alleviates Tyrosine Kinase Inhibitors-Induced Ferroptosis by Reprogramming Lipid Metabolism in P53 Wild-Type Liver Cancers.” Nature Communications 14 (1): 1–20. doi:10.1038/s41467-023-41852-z.